Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 43-50

  Ichihashi, Teruhisa ^a   Izawa, Mariko ^a   Miyata, Kenji ^a   Mizui, Takuji ^a   Hirano, Koichiro ^a   Takagishi, Yasushi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DIMETHOXYPHENYL) 3 (3 ETHYLVALERYL) 4 HYDROXY 6,7,8 TRIMETHOXY 2 NAPHTHOIC ACID METHYL ESTER; ALANINE; GLUCOSE; GLYCOCHOLIC ACID; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID SYNTHESIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; DOSE RESPONSE; DRUG MECHANISM; HYPERCHOLESTEROLEMIA; ILEUM MUCOSA; INTESTINE BRUSH BORDER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; ILEUM; INTESTINAL ABSORPTION; MALE; NAPHTHOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031887502     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ast M and Frishman WH (1990) Bile acid sequestrants. J Clin Pharmacol 30:99-106.
2. Beesley RC and Faust RG (1979) Sodium ion-coupled uptake of taurocholate by intestinal brush-border membrane vesicles. Biochem J 178:299-303.
3. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP and Csahin-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 257:3233-3240.
4. Bollman JL, Cain JC and Grindlay JH (1948) Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. J Lab Clin Med 33:1349-1352.
5. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin J, Kaplan C, Zhao X, Bisson BD, Fitzpatrick VF and Dodge HT (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323:1289-1298.
6. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edminston WA, Smink RD, Sawin HS, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC and the POSCH group (1990) Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the program on the surgical control of the hyperlipidemias (POSCH). N Engl J Med 323:946-955.
7. Crane RK (1977) The gradient hypothesis and other models of carrier mediated active transport. Rev Physiol Biochem Pharmacol 78:99-159.
8. Fears R, Brown R, Ferres F, Grenier F and Tyrrell AWR (1990) Effects of novel bile salts on cholesterol metabolism in rats and guinea-pigs. Biochem Pharmacol 40:2029-2037.
9. Glueck CJ, Ford S Jr, Scheel D and Steiner P (1972) Colestipol and cholestyramine resines: Comparative effects in familial type II hyperlipoproteinemia. J Am Med Assoc 222:676-681.
10. +/bile acid cotransporter inhibitor decrease serum cholesterol in hamsters. Life Sci 60:PL365-PL370.
11. Holt PR (1966) Competitive inhibition of intestinal bile salt absorption in rat. Am J Physiol 210:635-639.
12. Hopfer U, Sigrist-Nelson K, Ammann E and Murer H (1976) Differences in neutral amino acid glucose transport between brush border and basolateral membrane of intestinal epithelial cells. J Cell Physiol 89:805-810.
13. Hunninghake D (1986) Resins therapy: Adverse effects and their management, in Pharmacological Control of Hyperlipidaemia (Fears R ed) pp 67-89, J. R. Prous Science Publishers, Barcelona.
14. Kessler M, Acuto O, Storelli C, Murer H, Muller M and Semenza G (1978) A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Biochim Biophys Acta 506:136-154.
15. Krag E and Phillips F (1974) Active and passive bile acid absorption in man: Perfusion studies of the ileal and jejunum. J Clin Invest 53:1686-1694.
16. +-dependent bile acid transport activity in rabbit small intestine correlates with the coexpression of an integral 93-kDa and a peripheral 14-kDa bile acid-binding membrane protein along the duodenum-ileum axis. J Biol Chem 268:18035-18046.
17. Lack L and Weiner IM (1966) Intestinal bile salt transport: Structure-activity relationships and other properties. Am J Physiol 210:1142-1152.
18. Lack L, Walker JT and Singletary GD (1970) Ileal bile salt transport: In vivo studies of effect of substrate ionization on activity. Am J Physiol 219:487-490.
19. Leren TP, Hjermann I, Berg K, Leren P, Foss OP and Viksmoen L (1988) Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Atherosclerosis 73:135-141.
20. Lewis MC, Briaddy LE and Root C (1995) Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice. J Lipid Res 36:1098-1105.
21. Lipid Research Clinics Program (1984a) The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. J Am Med Assoc 251:351-364.
22. Lipid Research Clinics Program (1984b) The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 251:365-374.
23. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
24. Packard CJ and Shepherd J (1982) The hepatobiliary axis and lipoprotein metabolism: Effects of bile acid sequestrants and ileal bypass surgery. J Lipid Res 23:1081-1098.
25. Root C, Smith CD, Winegar DA, Brieaddy LE and Lewis MC (1995) Inhibition of ileal sodium-dependent bile acid transport by 2164U90. J Lipd Res 36:1106-1115.
26. Samuel P, Grouse JR and Ahrens EH Jr (1978) Evaluation of an isotope ratio method for measurement of cholesterol absorption in man. J Lipid Res 19:82-93.
27. Schneider BL, Dawson PA, Christie D-M, Hardikar W, Wong MH and Suchy FJ (1995) Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest 95:745-754.
28. Takashima K, Kohno T, Mori T, Ohtani A, Hirakoso K and Takeyama S (1994) The hypocholesterolemic action of TA-7552 and its effects on cholesterol in the rat. Atherosclerosis 107:247-257.
29. Vega GL and Grundy SM (1987) Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol. J Am Med Assoc 257:33-38.
30. Wess G, Kramer W, Enhsen A, Glombik H, Baringhaus K-H, Böger G, Urmann M, Bock K, Kleine H, Neckermann G, Hoffmann A, Pittius C, Falk E, Fehlhaber H.-W, Kogler H. and Friedrich M (1994) Specific inhibitors of ileal bile acid transport. J Med Chem 37: 873-875,.
31. Wilson FA Intestinal transport of bile acids. Am J Physiol 241: G83-G92, 1981.
32. Wong MH, Oelkers P, Craddock AL and Dawson PA (1994) Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 269:1340-1347.
33. Wong MH, Oelkers P and Dawson PA (1995) Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J Biol Chem 270:27228-27234.
34. Zilversmit DB (1972) A single blood sample dual isotope method for the measurement of cholesterol absorption in rats. Proc Soc Exp Biol Med 140:862-865.
35. Zilversmit DB and Hughes LB (1974)Validation of a dual-isotope plasma ratio method for measurement of cholesterol absorption in rats. J Lipid Res 15: 465-473.